Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Immunogen Inc (IMGN)  
$31.23 0.00 (0.00%) as of 4:30 Thu 2/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 264,900,000
Market Cap: 8.27(B)
Last Volume: 49,305,461 Avg Vol: 6,443,121
52 Week Range: $12.46 - $31.23
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  606
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 546,050 4,785,085 4,785,085
Total Sell Value $0 $15,925,514 $86,338,289 $86,338,289
Total People Sold 0 5 5 5
Total Sell Transactions 0 11 26 26
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 453
  Page 19 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Skaletsky Mark B Director   –       •      –    2003-10-01 4 A $4.45 $4,499 D/D 1,011 11,458     -
   Skaletsky Mark B Director   –       •      –    2003-07-14 4 A $4.27 $2,998 D/D 702 10,447     -
   Shire Pharmaceuticals Group Plc 10% Owner   –       –       •   2003-05-13 3 IO $0.00 $0 D/D 0 4,096,098     -

  453 Records found
  Previous  10  11  12  13  14  15  16  17  18  19    
  Page 19 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed